To test the relevance of cytoplasmic EZH2 to the neoplastic functions of breast cancer we developed an EZH2 mutant lacking the nuclear localization domain (ΔNLS-EZH2) (Fig. 3c). This evidence concerns the gene EZH2 and breast carcinoma.